Five Prime Therapeutics, Inc. Financing Cash Flow
Five Prime Therapeutics, Inc. reported Financing Cash Flow of $188.91 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-03-22
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $189.29M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-09-30 was -$307.00K.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-06-30 was $196.00K, a 72.51% decline year-over-year.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-03-31 was -$277.00K.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $188.91M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2019 was -$463.00K, a 100.42% decline from fiscal 2018.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $109.17M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2017 was -$9.89M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2020-12-31 | $189.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $188.99M derived: sum of 2 quarters · filed 2021-03-22 | $189.18M derived: sum of 3 quarters · filed 2021-03-22 | $188.91M 10-K · filed 2021-03-22 |
| 2020-09-30 | -$307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$111.00K derived: sum of 2 quarters · filed 2020-11-03 | -$388.00K 10-Q · filed 2020-11-03 | -$415.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$81.00K 10-Q · filed 2020-08-06 | -$108.00K derived: sum of 3 quarters · filed 2021-03-22 | -$809.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-03-31 | -$277.00K 10-Q · filed 2020-05-07 | -$304.00K derived: sum of 2 quarters · filed 2021-03-22 | -$1.00M derived: sum of 3 quarters · filed 2021-03-22 | -$292.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$728.00K derived: sum of 2 quarters · filed 2021-03-22 | -$15.00K derived: sum of 3 quarters · filed 2021-03-22 | -$463.00K 10-K · filed 2021-03-22 |
| 2019-09-30 | -$701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $12.00K derived: sum of 2 quarters · filed 2020-11-03 | -$436.00K 10-Q · filed 2020-11-03 | -$44.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-06-30 | $713.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $265.00K 10-Q · filed 2020-08-06 | $657.00K derived: sum of 3 quarters · filed 2021-03-22 | $60.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-03-31 | -$448.00K 10-Q · filed 2020-05-07 | -$56.00K derived: sum of 2 quarters · filed 2021-03-22 | -$653.00K derived: sum of 3 quarters · filed 2021-03-22 | $405.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2018-12-31 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$205.00K derived: sum of 2 quarters · filed 2021-03-22 | $853.00K derived: sum of 3 quarters · filed 2021-03-22 | $109.17M 10-K · filed 2021-03-22 |
| 2018-09-30 | -$597.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $461.00K derived: sum of 2 quarters · filed 2019-11-06 | $108.78M 10-Q · filed 2019-11-06 | $109.90M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $109.38M 10-Q · filed 2019-08-08 | $110.50M derived: sum of 3 quarters · filed 2020-02-27 | $109.45M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $108.32M 10-Q · filed 2019-05-09 | $109.44M derived: sum of 2 quarters · filed 2020-02-27 | $108.39M derived: sum of 3 quarters · filed 2020-02-27 | |
| 2017-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $69.00K derived: sum of 2 quarters · filed 2020-02-27 | -$9.89M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$11.01M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$9.96M 10-Q · filed 2018-08-08 | |||
| 2016-12-31 | -$8.85M 10-K · filed 2019-02-26 | |||
| 2014-06-30 | $686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $59.98M 10-Q · filed 2014-08-07 | $58.99M derived: sum of 3 quarters · filed 2014-08-07 | $124.72M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | $59.29M 10-Q · filed 2014-05-12 | $58.30M derived: sum of 2 quarters · filed 2014-05-12 | $124.04M derived: sum of 3 quarters · filed 2014-05-12 | $123.56M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-12-31 | -$985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $64.75M derived: sum of 2 quarters · filed 2014-03-26 | $64.27M derived: sum of 3 quarters · filed 2014-08-07 | $64.28M 10-K · filed 2014-03-26 |
| 2013-09-30 | $65.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $65.25M derived: sum of 2 quarters · filed 2014-08-07 | $65.27M 10-Q · filed 2013-11-13 | $65.29M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-06-30 | -$478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$466.00K 10-Q · filed 2014-08-07 | -$442.00K derived: sum of 3 quarters · filed 2014-08-07 | |
| 2013-03-31 | $12.00K 10-Q · filed 2014-05-12 | $36.00K derived: sum of 2 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $6.91M 10-K · filed 2014-03-26 | ||
| 2012-09-30 | $6.88M 10-Q · filed 2013-11-13 | |||
| 2011-12-31 | $26.00K 10-K · filed 2014-03-26 |